Buckingham Capital Management (Ohio)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $12.9M | Buy |
98,753
+1,251
| +1% | +$175K | 1.48% | 21 |
|
|
2024
Q3 | $15.2M | Sell |
97,502
-5,067
| -5% | -$818K | 1.74% | 15 |
|
|
2024
Q2 | $16M | Sell |
102,569
-1,542
| -1% | -$232K | 1.91% | 15 |
|
|
2024
Q1 | $14.1M | Buy |
104,111
+3,354
| +3% | +$444K | 1.73% | 16 |
|
|
2023
Q4 | $13.6M | Buy |
100,757
+953
| +1% | +$124K | 1.82% | 15 |
|
|
2023
Q3 | $13.5M | Buy |
99,804
+1,656
| +2% | +$226K | 2.06% | 14 |
|
|
2023
Q2 | $14M | Sell |
98,148
-2,616
| -3% | -$385K | 2.09% | 14 |
|
|
2023
Q1 | $14M | Buy |
100,764
+1,364
| +1% | +$184K | 2.24% | 11 |
|
|
2022
Q4 | $13.5M | Buy |
99,400
+1,107
| +1% | +$139K | 2.35% | 10 |
|
|
2022
Q3 | $10.8M | Buy |
98,293
+3,233
| +3% | +$410K | 2.09% | 14 |
|
|
2022
Q2 | $12.6M | Sell |
95,060
-2,328
| -2% | -$305K | 2.35% | 12 |
|
|
2022
Q1 | $12.9M | Buy |
97,388
+1,066
| +1% | +$128K | 2.12% | 14 |
|
|
2021
Q4 | $11.2M | Buy |
96,322
+2,053
| +2% | +$242K | 1.74% | 20 |
|
|
2021
Q3 | $11.3M | Buy |
94,269
+2,882
| +3% | +$335K | 1.85% | 18 |
|
|
2021
Q2 | $10.9M | Buy |
91,387
+2,361
| +3% | +$259K | 1.77% | 20 |
|
|
2021
Q1 | $8.85M | Buy |
89,026
+971
| +1% | +$97.6K | 1.49% | 24 |
|
|
2020
Q4 | $8.8M | Buy |
88,055
+1,765
| +2% | +$187K | 1.55% | 24 |
|
|
2020
Q3 | $9.46M | Buy |
86,290
+3,925
| +5% | +$437K | 1.88% | 16 |
|
|
2020
Q2 | $8.71M | Buy |
82,365
+9,600
| +13% | +$991K | 1.9% | 15 |
|
|
2020
Q1 | $6.5M | Sell |
72,765
-9,208
| -11% | -$867K | 1.63% | 17 |
|
|
2019
Q4 | $8.17M | Buy |
81,973
+10,180
| +14% | +$958K | 1.42% | 19 |
|
|
2019
Q3 | $6.4M | Buy |
71,793
+19,426
| +37% | +$1.68M | 1.19% | 24 |
|
|
2019
Q2 | $4.32M | Buy |
52,367
+23,319
| +80% | +$1.83M | 0.82% | 38 |
|
|
2019
Q1 | $2.35M | Buy |
29,048
+15,422
| +113% | +$1.22M | 0.46% | 58 |
|
|
2018
Q4 | $1.03M | Sell |
13,626
-13
| -0.1% | -$1.01K | 0.23% | 87 |
|
|
2018
Q3 | $1.08M | Buy |
13,639
+158
| +1% | +$11.9K | 0.21% | 94 |
|
|
2018
Q2 | $947K | Buy |
13,481
+572
| +4% | +$41.2K | 0.19% | 98 |
|
|
2018
Q1 | $903K | Buy |
12,909
+265
| +2% | +$18.4K | 0.19% | 102 |
|
|
2017
Q4 | $877K | Buy |
12,644
+528
| +4% | +$35.6K | 0.18% | 106 |
|
|
2017
Q3 | $821K | Buy |
12,116
+502
| +4% | +$31.7K | 0.18% | 107 |
|
|
2017
Q2 | $792K | Buy |
+11,614
| New | +$758K | 0.18% | 108 |
|
|
2014
Q2 | – | Sell |
-7,794
| Closed | -$506K | – | 174 |
|
|
2014
Q1 | $506K | Buy |
7,794
+286
| +4% | +$18.5K | 0.17% | 131 |
|
|
2013
Q4 | $446K | Buy |
7,508
+130
| +2% | +$7.06K | 0.16% | 136 |
|
|
2013
Q3 | $382K | Buy |
7,378
+443
| +6% | +$22.3K | 0.16% | 137 |
|
|
2013
Q2 | $328K | Buy |
+6,935
| New | +$353K | 0.13% | 137 |
|
Other funds holding AZN
Buckingham Capital Management (Ohio)'s AZN Position: Q4 2024 in Review
Buckingham Capital Management (Ohio) increased its AstraZeneca (AZN) stake by 1.3% in Q4 2024, buying an estimated $175K and bringing the position to 98,753 shares worth $12.9M. The position accounts for 1.48% of the portfolio, ranked #21.
Buckingham Capital Management (Ohio) first reported a position in AZN in Q2 2013 and has held it in 35 quarters since. The position peaked at $16M in Q2 2024. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.
- Buckingham Capital Management (Ohio) held 98,753 shares of AstraZeneca worth $12.9M as of Q4 2024.
- Buckingham Capital Management (Ohio) bought 1,251 AstraZeneca shares in Q4 2024, an estimated $175K.
- AstraZeneca made up 1.48% of Buckingham Capital Management (Ohio)'s portfolio in Q4 2024, its #21 holding.
- Buckingham Capital Management (Ohio) first reported a position in AstraZeneca in Q2 2013 and has held it in 35 quarters since.
- Buckingham Capital Management (Ohio)'s AstraZeneca position peaked at $16M in Q2 2024.
- 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.
Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2024, filed 31 Jan 2025.